Goeroe1980 schreef:
Instead, buying promising small to medium-sized companies -- such as Dutch vaccine maker Crucell which has a market capitalisation of some 1 billion euros -- may be more manageable, according to analysts.
story is toch nog niet over zo lijkt het.......